Found: 23
Select item for more details and to access through your institution.
Chronische lymphatische Leukämie: aktuelle Standards und neue Therapieansätze.
- Published in:
- Der Internist, 2014, v. 55, n. 12, p. 1400, doi. 10.1007/s00108-014-3556-0
- By:
- Publication type:
- Article
Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 1, p. e2052, doi. 10.1038/cddis.2015.382
- By:
- Publication type:
- Article
Barium in Deep-sea Sediments of the Atlantic Ocean.
- Published in:
- Nature, 1964, v. 201, n. 4920, p. 696, doi. 10.1038/201696b0
- By:
- Publication type:
- Article
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 2, p. 329, doi. 10.1038/leu.2014.196
- By:
- Publication type:
- Article
A PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX COMPARED TO OBINUTUZUMAB AND VENETOCLAX IN PATIENTS WITH HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 851, doi. 10.1002/hon.3166_OT30
- By:
- Publication type:
- Article
Safety of acalabrutinib treatment in very old (≥80 y) and/or frail patients with chronic lymphocytic leukemia ‐ interim safety analysis of the ongoing phase II CLL‐Frail trial.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 468, doi. 10.1002/hon.3164_344
- By:
- Publication type:
- Article
IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 56, doi. 10.1002/hon.3163_24
- By:
- Publication type:
- Article
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 58, doi. 10.1002/hon.3163_25
- By:
- Publication type:
- Article
Deep learning can predict presence of TP53 aberrations and IGHV mutational status from peripheral blood smears of chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 305, doi. 10.1002/hon.3164_213
- By:
- Publication type:
- Article
Characterization of the genetic and epigenetic landscape of B‐cell neoplasms with IG::BCL3‐translocation.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 248, doi. 10.1002/hon.3164_161
- By:
- Publication type:
- Article
A CONTINUOUS INDIVIDUALIZED RISK INDEX FOR REFINED OUTCOME PREDICTION AFTER TARGETED THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CIRI‐CLL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.51_2880
- By:
- Publication type:
- Article
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.49_2880
- By:
- Publication type:
- Article
VENETOCLAX‐OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION‐BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.31_2879
- By:
- Publication type:
- Article
GENETIC MARKERS AND OUTCOME WITH FRONT LINE OBINUTUZUMAB PLUS EITHER CHLORAMBUCIL OR VENETOCLAX ‐ UPDATED ANALYSIS OF THE CLL14 TRIAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.30_2879
- By:
- Publication type:
- Article
BENDAMUSTINE, FOLLOWED BY OBINUTUZUMAB, ACALABRUTINIB AND VENETOCLAX IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAAG TRIAL OF THE GCLLSG.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.34_2879
- By:
- Publication type:
- Article
THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.161_2880
- By:
- Publication type:
- Article
IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 38, doi. 10.1002/hon.7_2629
- By:
- Publication type:
- Article
HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 104, doi. 10.1002/hon.68_2629
- By:
- Publication type:
- Article
GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORABMUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY Best abstract submitted by a young investigator / travel grant recipient.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 84, doi. 10.1002/hon.53_2629
- By:
- Publication type:
- Article
IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 38, doi. 10.1002/hon.7_2629
- By:
- Publication type:
- Article
HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 104, doi. 10.1002/hon.68_2629
- By:
- Publication type:
- Article
GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORABMUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY Best abstract submitted by a young investigator / travel grant recipient.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 84, doi. 10.1002/hon.53_2629
- By:
- Publication type:
- Article
Ethyl-Zinc(II)-Cation Equivalents: Synthesis and Hydroamination Catalysis.
- Published in:
- Chemistry - A European Journal, 2015, v. 21, n. 39, p. 13696, doi. 10.1002/chem.201502328
- By:
- Publication type:
- Article